ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

被引:269
作者
Miettinen, Markku [1 ]
Wang, Zeng-Feng [1 ]
Paetau, Anders [4 ]
Tan, Shyh-Han [2 ,3 ]
Dobi, Albert [2 ,3 ]
Srivastava, Shiv [2 ,3 ]
Sesterhenn, Isabell [1 ]
机构
[1] Armed Forces Inst Pathol, Washington, DC 20306 USA
[2] Walter Reed Army Med Ctr, Ctr Prostate Dis Res, Washington, DC USA
[3] Uniformed Serv Univ Hlth Sci, Rockville, MD USA
[4] Helsinki Univ Hosp, Helsinki, Finland
关键词
ETS-family transcription factor; ERG; angiosarcoma; hemangioendothelioma; hemangioma; immunohistochemistry; prostate carcinoma; EXPRESSION; CELL; ANTIBODY; CD34; SPECIFICITY; PODOPLANIN; PHENOTYPES; DIAGNOSIS; ANTIGEN; TISSUES;
D O I
10.1097/PAS.0b013e318206b67b
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
ERG, an ETS family transcription factor, is known to be expressed in endothelial cells, and oncogenic ERG gene fusions occur in subsets of prostatic carcinoma, acute myeloid leukemia, and Ewing sarcoma. In this study, we immunohistochemically investigated nuclear ERG expression using a new monoclonal antibody, CPDR ERG-MAb, that is highly specific for detecting ERG protein and ERG-expressing prostate carcinomas. A broad range of vascular endothelial (n = 250), other mesenchymal (n = 973), and epithelial tumors (n = 657) was examined to determine the use of ERG immunohistochemistry in surgical pathology. Only immunostains with ERG-positive normal endothelia (internal control) were considered valid, and only nuclear staining was considered to be positive. In adult tissues, ERG was restricted to endothelial cells and to a subset of bone marrow precursors, but early fetal mesenchyme and subpopulations of fetal cartilage were also positive. In vascular tumors, ERG was expressed in endothelia of all hemangiomas and lymphangiomas, and typically extensively expressed in 96 of 100 angiosarcomas, 42 of 43 epithelioid hemangioendotheliomas, and all 26 Kaposi sarcomas. Among nonvascular mesenchymal tumors, only blastic extramedullary myeloid tumors (7 of 10) and rare Ewing sarcomas (2 of 29) were positive. Among epithelial tumors, 30 of 66 prostatic adenocarcinomas showed focal-to-extensive ERG positivity, with no immunoreactivity in the normal prostate. Other carcinomas and epithelial tumors (n= 643) were ERG negative, with the exception of 1 of 42 large cell undifferentiated pulmonary carcinomas and 1 of 27 mesotheliomas, each of which showed focal nuclear ERG positivity. On the basis of the above observations, ERG is a highly specific new marker for benign and malignant vascular tumors. Among epithelial tumors, ERG shows a great promise as a marker to identify prostatic carcinoma in both primary and metastatic settings.
引用
收藏
页码:432 / 441
页数:10
相关论文
共 35 条
[1]  
Baltzinger M, 1999, DEV DYNAM, V216, P420, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<420::AID-DVDY10>3.0.CO
[2]  
2-C
[3]   Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin [J].
Birdsey, Graeme M. ;
Dryden, Nicola H. ;
Amsellem, Valerie ;
Gebhardt, Frank ;
Sahnan, Kapil ;
Haskard, Dorian O. ;
Dejana, Elisabetta ;
Mason, Justin C. ;
Randi, Anna M. .
BLOOD, 2008, 111 (07) :3498-3506
[4]   Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium [J].
Breiteneder-Geleff, S ;
Soleiman, A ;
Kowalski, H ;
Horvat, R ;
Amann, G ;
Kriehuber, E ;
Diem, K ;
Weninger, W ;
Tschachler, E ;
Alitalo, K ;
Kerjaschki, D .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) :385-394
[5]  
De Young B R., 1993, Appl Immunohistochem, V1, P97
[6]   Atypical and malignant glomus tumors - Analysis of 52 cases, with a proposal for the reclassification of glomus tumors [J].
Folpe, AL ;
Fanburg-Smith, JC ;
Miettinen, M ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (01) :1-12
[7]   ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification [J].
Furusato, B. ;
Tan, S-H ;
Young, D. ;
Dobi, A. ;
Sun, C. ;
Mohamed, A. A. ;
Thangapazham, R. ;
Chen, Y. ;
McMaster, G. ;
Sreenath, T. ;
Petrovics, G. ;
McLeod, D. G. ;
Srivastava, S. ;
Sesterhenn, I. A. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (03) :228-237
[8]   A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy [J].
Fury, MG ;
Antonescu, CR ;
Van Zee, KJ ;
Brennan, MF ;
Maki, RG .
CANCER JOURNAL, 2005, 11 (03) :241-247
[9]   EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma [J].
Ginsberg, JP ;
de Alava, E ;
Ladanyi, M ;
Wexler, LH ;
Kovar, H ;
Paulussen, M ;
Zoubek, A ;
Dockhorn-Dworniczak, B ;
Juergens, H ;
Wunder, JS ;
Andrulis, IL ;
Malik, R ;
Sorensen, PHB ;
Womer, RB ;
Barr, FG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1809-1814
[10]   CELLULAR HEMANGIOMAS (HEMANGIOENDOTHELIOMAS) IN INFANTS - LIGHT MICROSCOPIC, IMMUNOHISTOCHEMICAL, AND ULTRASTRUCTURAL OBSERVATIONS [J].
GONZALEZCRUSSI, F ;
REYESMUGICA, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1991, 15 (08) :769-778